- Home
- TSVT vs SWZ Comparison
TSVT vs SWZ Comparison
Compare TSVT & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- SWZ
- Stock Information
- Founded
- TSVT 2021
- SWZ 1986
- Country
- TSVT United States
- SWZ United States
- Employees
- TSVT N/A
- SWZ N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- SWZ Finance Companies
- Sector
- TSVT Health Care
- SWZ Finance
- Exchange
- TSVT Nasdaq
- SWZ Nasdaq
- Market Cap
- TSVT 128.5M
- SWZ 112.9M
- IPO Year
- TSVT N/A
- SWZ N/A
- Fundamental
- Price
- TSVT $2.61
- SWZ $8.93
- Analyst Decision
- TSVT Buy
- SWZ
- Analyst Count
- TSVT 4
- SWZ 0
- Target Price
- TSVT $8.50
- SWZ N/A
- AVG Volume (30 Days)
- TSVT 278.0K
- SWZ 14.2K
- Earning Date
- TSVT 03-04-2025
- SWZ 01-01-0001
- Dividend Yield
- TSVT N/A
- SWZ 6.59%
- EPS Growth
- TSVT N/A
- SWZ N/A
- EPS
- TSVT N/A
- SWZ N/A
- Revenue
- TSVT $45,620,000.00
- SWZ N/A
- Revenue This Year
- TSVT N/A
- SWZ N/A
- Revenue Next Year
- TSVT $37.70
- SWZ N/A
- P/E Ratio
- TSVT N/A
- SWZ N/A
- Revenue Growth
- TSVT N/A
- SWZ N/A
- 52 Week Low
- TSVT $2.29
- SWZ $7.12
- 52 Week High
- TSVT $6.00
- SWZ $8.57
- Technical
- Relative Strength Index (RSI)
- TSVT 50.02
- SWZ 71.86
- Support Level
- TSVT $2.38
- SWZ $8.78
- Resistance Level
- TSVT $2.82
- SWZ $8.91
- Average True Range (ATR)
- TSVT 0.18
- SWZ 0.07
- MACD
- TSVT 0.04
- SWZ -0.01
- Stochastic Oscillator
- TSVT 58.18
- SWZ 89.19
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, and retail.